The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Adjuvants and Antibody Production: Dispelling the Myths Associated with Freund's Complete and Other Adjuvants
Abstract
Adjuvants have been used for more than 70 yr to enhance the immune response of the host animal to an antigen. Among the mechanisms that adjuvants use to enhance the immune response are the "depot" effect, antigen presentation, antigen targeting, immune activation/modulation, and cytotoxic lymphocyte induction. The immunostimulatory properties of adjuvants result in inflammation, tissue destruction, and the potential for resulting pain and distress in the host animal. The inflammatory lesions produced by adjuvants such as Freund's complete adjuvant (FCA) have led some to conclude that pain and distress are present, even in cases where the scientific evidence fails to support this conclusion. Recommendations and regulations in the literature, based on available scientific evidence, provide guidance on total adjuvant volumes, volumes per site, routes of injection, booster injections, and adjuvants used for antibody production. Among the numerous adjuvants that are used for experimental antibody production reviewed in this article, many claim to be less inflammatory, tissue destructive, and painful than FCA while producing equal or superior antibody responses. Although no adjuvant surpasses FCA for experimental antibody production against a wide range of antigenic molecules, many produce excellent antibody responses with less inflammation and tissue destruction. Balancing the requisite degree of immuno-stimulation and the extent of inflammation, necrosis, and potential pain and distress requires consideration of the nature of the antigen, the host immune responsiveness, the adjuvant's mechanisms of action, and the desired end-product. In cases where the antigen is a weak immunogen or has a very limited availability, the type and role of adjuvant becomes a critical component in producing an acceptable immune response and humoral antibody response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Journal of the American Veterinary Medical Association
Nelson, A. M., Jones, M., & Craig, L. E. (2013) · Journal of the American Veterinary Medical Association · Cited by 4,493
Handbook of Experimental Immunology.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-6-1376_1 · Cited by 2,408
Clinical and Experimental Immunology
Kay, H. (1966) · PubMed Central · Cited by 2,177
Robbins pathologic basis of disease
Cotran, R. S., Kumar, V., & Collins, T. (1989) · Medical Entomology and Zoology · Cited by 1,944
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R.-B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,661
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
Bauer, S., Kirschning, C. J., Häcker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., & Lipford, G. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293498 · Cited by 1,533
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,479
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Methods in molecular medicine.
Craig, R. K. (1987) · BMJ · doi:10.1136/bmj.295.6599.646 · Cited by 1,057
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
Ellouz, F., Adam, A., Ciorbaru, R., & Lederer, E. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90458-6 · Cited by 1,019
Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., & Nussenzweig, M. C. (1995) · Nature · doi:10.1038/375151a0 · Cited by 964
Bonifaz, L. C., Bonnyay, D. P., Charalambous, A., Darguste, D. I., Fujii, S.-I., Soares, H., Brimnes, M. K., Moltedo, B., Moran, T. M., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032220 · Cited by 921
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
Adjuvants—a classification and review of their modes of action
Cox, J. C., & Coulter, A. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00183-1 · Cited by 682
Aluminum compounds as vaccine adjuvants
Gupta, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00008-8 · Cited by 623
The Biology of the Laboratory Rabbit
(1974) · Elsevier eBooks · doi:10.1016/c2013-0-11681-9 · Cited by 618
Lanzavecchia, A. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.004013 · Cited by 590
Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells
Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K. J., Takeshita, S., Gursel, M., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3555 · Cited by 570
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 564
(1987) · Laboratory Animals · doi:10.1177/002367728702100217 · Cited by 559
Hsu, F. J., Caspar, C. B., Czerwinski, D., Kwak, L. W., Liles, T. M., Syrengelas, A., Taidi-Laskowski, B., & Levy, R. (1997) · Blood · doi:10.1182/blood.v89.9.3129 · Cited by 452
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Biodegradable microspheres as a vaccine delivery system
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., & Gilley, R. M. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90076-v · Cited by 399
Sensitization to Horse Serum by Means of Adjuvants
Freund, J., & McDermott, K. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-49-13625 · Cited by 368
Allison, A. C., & Byars, N. E. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90402-3 · Cited by 315
Sensitization and Antibody Formation after Injection of Tubercle Bacilli and Paraffin Oil.
Freund, J., Casals, J., & Hosmer, E. P. (1937) · Experimental Biology and Medicine · doi:10.3181/00379727-37-9625 · Cited by 311
Current Status of Immunological Adjuvants
Warren, H. S., Vogel, F. R., & Chedid, L. A. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.002101 · Cited by 283
Quesniaux, V. J., Nicolle, D. M., Torres, D., Kremer, L., Guérardel, Y., Nigou, J., Puzo, G., Erard, F., & Ryffel, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4425 · Cited by 259
Taking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258
Salk, J. E., Bennett, B. L., Lewis, L. J., Ward, E. N., & Youngner, J. S. (1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.13.1081 · Cited by 218
A Compendium of Vaccine Adjuvants and Excipients
Vogel, F. R., & Powell, M. F. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_7 · Cited by 217
Control of Influenza and Poliomyelitis with Killed Virus Vaccines
Salk, J., & Salk, D. (1977) · Science · doi:10.1126/science.320661 · Cited by 183
Review of Polyclonal Antibody Production Procedures in Mammals and Poultry
Hanly, W. C., Artwohl, J. E., & Bennett, B. T. (1995) · ILAR Journal · doi:10.1093/ilar.37.3.93 · Cited by 169
The role of Toll-like receptors in immunity against mycobacterial infection
Heldwein, K. A., & Fenton, M. J. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01611-8 · Cited by 161
A retrospective review of lesions associated with the use of Freund's adjuvant.
Broderson (1989) · PubMed · Cited by 161
Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response
Nigou, J., Gilleron, M., Rojas, M., García, L. F., Thurnher, M., & Puzo, G. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01621-0 · Cited by 149
Vaccine adjuvants : preparation methods and research protocols
O’Hagan, D. T. (2000) · Humana Press eBooks · Cited by 124
A comparison of commercially available adjuvants for use in research
Bennett, B., Check, I. J., Olsen, M. R., et al. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90302-a · Cited by 124
Hunter, R. L., & Bennett, B. T. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.6.3167 · Cited by 122
The theory and practical application of adjuvants
Stewart-Tull, D. E. S. (1995) · Cited by 119
Giffen, P. S., Turton, J. A., Andrews, C. M., Barrett, P., Clarke, C. J., Fung, K.-W., Munday, M. R., Roman, I., Smyth, R., Walshe, K., et al. (2003) · Archives of Toxicology · doi:10.1007/s00204-003-0458-7 · Cited by 112
Leenaars, M., Rotterdam, Koedam, M. A., Wester, P. W., Baumans, V., Claassen, E., & Hendriksen, C. F. M. (1998) · Laboratory Animals · doi:10.1258/002367798780599884 · Cited by 107
Silverman, J., Suckow, M. A., & Murthy, S. (2006) · CRC Press eBooks · doi:10.1201/b12106 · Cited by 102
Effect of Bacteria and Bacterial Products on Antibody Response
Muñoz, J. (1964) · Advances in immunology · doi:10.1016/s0065-2776(08)60712-9 · Cited by 102
The Adjuvant Activity of Nonionic Block Polymer Surfactants
HUNTER, R. L., & Bennett, B. T. (1986) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1986.tb01970.x · Cited by 100
Leenaars, M., Hendriksen, C. F. M., de Leeuw, W. A., Carat, F., Delahaut, P., Fischer, R. W., Halder, M., Hanly, W. C., Hartinger, J., Hau, J., et al. (1999) · Alternatives to Laboratory Animals · doi:10.1177/026119299902700106 · Cited by 94
Some Observations on the Use of Alum Precipitated Diphtheria Toxoid
Harrison, W. T. (1935) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.25.3.298 · Cited by 64
Review of Selected Adjuvants Used in Antibody Production
Jennings, V. M. (1995) · ILAR Journal · doi:10.1093/ilar.37.3.119 · Cited by 60
Control of animal pain and distress in antibody production and infectious disease studies
Amyx, H. L. (1987) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1987.191.10.1287 · Cited by 60
Signal Integration Following Toll-like Receptor Triggering
Dalpke, A. H., & Heeg, K. M. (2002) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v22.i3.40 · Cited by 57
Lyle, W. M. (1994) · Optometry and Vision Science · doi:10.1002/j.1538-9235.1994.tb03342.x · Cited by 56
Direction of Research on Vaccination against Influenza—New Studies with Immunologic Adjuvants
SALK, J. E., Laurent, A. M., & Bailey, M. L. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.6.669 · Cited by 55
Byars, N. E., ALLISON, A. C., Harmon, M. W., & Kendal, A. P. (1990) · Vaccine · doi:10.1016/0264-410x(90)90177-n · Cited by 52
Polyclonal Antibody Production
Stills, H. F. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-380920-9.00011-0 · Cited by 46
Smith, D. E., O'Brien, M. E., Palmer, V., & Sadowski, J. A. (1992) · PubMed · Cited by 44
Institutional Policies and Guidelines on Adjuvants and Antibody Production
Jackson, L. R., & Fox, J. G. (1995) · ILAR Journal · doi:10.1093/ilar.37.3.141 · Cited by 44
Internalization of Iscom-Borne Antigens and Presentation under MHC Class I or Class II Restriction
Villacres, M. C., Behboudi, S., Nikkila, T., Lövgren-Bengtsson, K., & Morein, B. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1278 · Cited by 40
Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs
Kandimalla, E. R., Zhu, F., Bhagat, L., Yu, D. S., & Agrawal, S. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310654 · Cited by 37
Beacock‐Sharp, H. (2003) · International Immunology · doi:10.1093/intimm/dxg067 · Cited by 25
Edelman, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-083-7:1 · Cited by 24
Antibody Response in Sheep Following Immunization with Streptococcus bovis in Different Adjuvants
Shu, Q., Bird, S. H., Gill, H. S., Duan, E., Xu, Y., Hillard, M. A., & Rowe, J. B. (2001) · Veterinary Research Communications · doi:10.1023/a:1026757917968 · Cited by 21
Lövgren‐Bengtsson, K., & Morein, B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-083-7:239 · Cited by 17
Adjuvant Formulations for Experimental Vaccines
Stewart-Tull, D. E. S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-399-2:175 · Cited by 13
Hjorth, R. N., Bonde, G. M., Piner, E. D., Goldberg, K. M., & Levner, M. H. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00216-8 · Cited by 12
Physiologic and behavioral assessment of rabbits immunized with Freund's complete adjuvant.
Halliday, L. C., Artwohl, J. E., Hanly, W. C., Bunte, R. M., & Bennett, B. T. (2000) · PubMed · Cited by 11
Cited by
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
Panel), E. P. O. G. M. O. (. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1700 · Cited by 608
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
Petrovsky, N. (2015) · Drug Safety · doi:10.1007/s40264-015-0350-4 · Cited by 366
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
Escolano, A., Steichen, J. M., Dosenovic, P., Kulp, D. W., Golijanin, J., Sok, D., Freund, N. T., Gitlin, A. D., Oliveira, T., Araki, T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.030 · Cited by 320
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Facciolà, A., Visalli, G., Laganà, A., & Di Pietro, A. (2022) · Vaccines · doi:10.3390/vaccines10050819 · Cited by 316
Metadata
- Authors
- Stils, H. F.
- Venue
- ILAR Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 46
- Issue
- 3
- Pages
- 280-293
- ISSN
- 1084-2020 (ISSN-L)
- OpenAlex
- W2074065268
- Cited by
- 434
- References
- 70
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.